ARCHIVES

Broder Explains Where R01 Money Has Gone

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

In Brief: Gene Therapy For ADA Deficiency Moves forward With Stem Cell Treatment In Caif. And At NIH

June 18, 1993

DCBDC Board Cool to Proposals On Study Sections

November 23, 1990

Guest Editorial: Group Chairs Urge Implementation of NCI plan. Next Step: Bioinformatics and Tissue Banks

November 11, 2011

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005